Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103764347> ?p ?o ?g. }
- W2103764347 endingPage "222" @default.
- W2103764347 startingPage "214" @default.
- W2103764347 abstract "Total prostate-specific antigen (tPSA), ratio of free PSA (fPSA) to tPSA (%fPSA), and PSA density (PSAD) testing have a very low accuracy in the detection of prostate cancer (PCa). There is an urgent need for more accurate biomarkers.To compare the diagnostic accuracy of PSA isoform p2PSA and its derivatives in determining the presence of PCa at initial biopsy with the accuracy of other predictors in patients with tPSA 2.0-10 ng/ml.We conducted an observational prospective study in a real clinical setting of consecutive men with tPSA 2.0-10 ng/ml and negative digital rectal examination who were scheduled for prostate biopsy at a tertiary academic center.Outpatient transrectal ultrasound-guided prostate biopsies were performed according to a standardized institutional saturation scheme (18-22 cores).We determined the diagnostic accuracy of serum tPSA, %fPSA, PSAD, p2PSA, %p2PSA [(p2PSA/fPSA)×100] and the Beckman Coulter Prostate Health Index (phi; [p2PSA/fPSA×√tPSA]).Overall, 107 of 268 patients (39.9%) were diagnosed with PCa at extended prostate biopsies. Statistically significant differences between patients with and without PCa were observed for age, prostate and transition zone volume, PSAD, %p2PSA, and phi (all p values<0.05). In univariate accuracy analysis, phi and %p2PSA were the most accurate predictors of PCa (area under the curve: 75.6% and 75.7%, respectively), followed by transition zone volume (66%), prostate volume (65%), patient age (63%), PSAD (61%), %fPSA (58%), and tPSA (53%). In multivariate accuracy analyses, both phi (+11%) and %p2PSA (+10%) significantly improved the accuracy of established predictors in determining the presence of PCa at biopsy (p<0.001). Although %p2PSA and phi were significantly associated with Gleason score (Spearman ρ: 0.303 and 0.387, respectively; p ≤ 0.002), they did not improve the prediction of Gleason score ≥7 PCa in multivariable accuracy analyses (p > 0.05).In patients with a tPSA between 2.0 and 10 ng/ml, %p2PSA and phi are the strongest predictors of PCa at initial extended biopsies and are significantly more accurate than the currently used tests (tPSA, %fPSA, and PSAD) in determining the presence of PCa at biopsy." @default.
- W2103764347 created "2016-06-24" @default.
- W2103764347 creator A5001344641 @default.
- W2103764347 creator A5010393338 @default.
- W2103764347 creator A5016954165 @default.
- W2103764347 creator A5025584979 @default.
- W2103764347 creator A5028306255 @default.
- W2103764347 creator A5029049976 @default.
- W2103764347 creator A5032746256 @default.
- W2103764347 creator A5051984796 @default.
- W2103764347 creator A5053374936 @default.
- W2103764347 creator A5061623935 @default.
- W2103764347 creator A5063971650 @default.
- W2103764347 creator A5088744931 @default.
- W2103764347 creator A5091599102 @default.
- W2103764347 date "2011-08-01" @default.
- W2103764347 modified "2023-10-18" @default.
- W2103764347 title "Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting" @default.
- W2103764347 cites W1985014370 @default.
- W2103764347 cites W1992578553 @default.
- W2103764347 cites W2001107165 @default.
- W2103764347 cites W2016016515 @default.
- W2103764347 cites W2020441896 @default.
- W2103764347 cites W2044385780 @default.
- W2103764347 cites W2045239450 @default.
- W2103764347 cites W2083043726 @default.
- W2103764347 cites W2089300560 @default.
- W2103764347 cites W2098546186 @default.
- W2103764347 cites W2111089373 @default.
- W2103764347 cites W2112942915 @default.
- W2103764347 cites W2126157922 @default.
- W2103764347 cites W2140687262 @default.
- W2103764347 cites W2147236349 @default.
- W2103764347 cites W2328176404 @default.
- W2103764347 doi "https://doi.org/10.1016/j.eururo.2011.03.052" @default.
- W2103764347 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21482022" @default.
- W2103764347 hasPublicationYear "2011" @default.
- W2103764347 type Work @default.
- W2103764347 sameAs 2103764347 @default.
- W2103764347 citedByCount "165" @default.
- W2103764347 countsByYear W21037643472012 @default.
- W2103764347 countsByYear W21037643472013 @default.
- W2103764347 countsByYear W21037643472014 @default.
- W2103764347 countsByYear W21037643472015 @default.
- W2103764347 countsByYear W21037643472016 @default.
- W2103764347 countsByYear W21037643472017 @default.
- W2103764347 countsByYear W21037643472018 @default.
- W2103764347 countsByYear W21037643472019 @default.
- W2103764347 countsByYear W21037643472020 @default.
- W2103764347 countsByYear W21037643472021 @default.
- W2103764347 countsByYear W21037643472022 @default.
- W2103764347 countsByYear W21037643472023 @default.
- W2103764347 crossrefType "journal-article" @default.
- W2103764347 hasAuthorship W2103764347A5001344641 @default.
- W2103764347 hasAuthorship W2103764347A5010393338 @default.
- W2103764347 hasAuthorship W2103764347A5016954165 @default.
- W2103764347 hasAuthorship W2103764347A5025584979 @default.
- W2103764347 hasAuthorship W2103764347A5028306255 @default.
- W2103764347 hasAuthorship W2103764347A5029049976 @default.
- W2103764347 hasAuthorship W2103764347A5032746256 @default.
- W2103764347 hasAuthorship W2103764347A5051984796 @default.
- W2103764347 hasAuthorship W2103764347A5053374936 @default.
- W2103764347 hasAuthorship W2103764347A5061623935 @default.
- W2103764347 hasAuthorship W2103764347A5063971650 @default.
- W2103764347 hasAuthorship W2103764347A5088744931 @default.
- W2103764347 hasAuthorship W2103764347A5091599102 @default.
- W2103764347 hasConcept C121608353 @default.
- W2103764347 hasConcept C126322002 @default.
- W2103764347 hasConcept C126894567 @default.
- W2103764347 hasConcept C2775934546 @default.
- W2103764347 hasConcept C2776235491 @default.
- W2103764347 hasConcept C2780101318 @default.
- W2103764347 hasConcept C2780192828 @default.
- W2103764347 hasConcept C2781217009 @default.
- W2103764347 hasConcept C2781406297 @default.
- W2103764347 hasConcept C71924100 @default.
- W2103764347 hasConceptScore W2103764347C121608353 @default.
- W2103764347 hasConceptScore W2103764347C126322002 @default.
- W2103764347 hasConceptScore W2103764347C126894567 @default.
- W2103764347 hasConceptScore W2103764347C2775934546 @default.
- W2103764347 hasConceptScore W2103764347C2776235491 @default.
- W2103764347 hasConceptScore W2103764347C2780101318 @default.
- W2103764347 hasConceptScore W2103764347C2780192828 @default.
- W2103764347 hasConceptScore W2103764347C2781217009 @default.
- W2103764347 hasConceptScore W2103764347C2781406297 @default.
- W2103764347 hasConceptScore W2103764347C71924100 @default.
- W2103764347 hasIssue "2" @default.
- W2103764347 hasLocation W21037643471 @default.
- W2103764347 hasLocation W21037643472 @default.
- W2103764347 hasOpenAccess W2103764347 @default.
- W2103764347 hasPrimaryLocation W21037643471 @default.
- W2103764347 hasRelatedWork W1570285055 @default.
- W2103764347 hasRelatedWork W1979374145 @default.
- W2103764347 hasRelatedWork W1992657261 @default.
- W2103764347 hasRelatedWork W2099948048 @default.
- W2103764347 hasRelatedWork W2102167265 @default.
- W2103764347 hasRelatedWork W2143331076 @default.
- W2103764347 hasRelatedWork W2148869351 @default.